Expression Of Guanylyl Cyclase C And Its Prognostic Value In Different Developing Stages Of Colorectal Cancer Patients

Xiao-Hui Shi,Zhen Tan,Jun Shi,Yan Gu,Qiao Zuo,Xiao-Wen Xu,Li-Jun Tang,En-Da Yu
2017-01-01
Abstract:Background: Guanylyl cyclase C (GCC) is a specific and sensitive marker for colorectal cancers, which selectively express on epithelial cells from duodenum to the rectum. Currently the expression of GCC and its prognostic value of different stages of colorectal cancer have not been thoroughly investigated. Methods: Tissue microarray samples of 39 normal mucosa, 47 adenoma and 390 CRC (stage I-IV) tissues were immunohistochemically examined and assayed for GCC expression. Results: GCC were expressed on apical membrane and in cytoplasm. Expression of membranous but not cytoplasmic GCC increased significantly from stage I to stage II CRC (J. Nemenyi test, P=0.006). GCC membranous overexpression was associated with higher TNM (P=0.000), higher T stage (P=0.001) and higher N stage (P=0.000). Kaplan-Meier analyses showed that overexpression of membranous GCC was related to poor overall survival (P=0.025) and disease-free survival (P=0.005). Multivariate analyses showed that higher GCC membranous expression (P=0.014 for OS and P=0.018 for DFS) was independent predictive hazard factors of poor prognosis. Conclusion: GCC membranous expression is a valuable prognostic indicator for colorectal cancer and would be useful in tumor staging especially for stage II tumor diagnosis and treatment selection.
What problem does this paper attempt to address?